CNSX:MMJMatica Enterprises Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Matica Enterprises Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add C$0.03 0.00 (0.00 %) (As of 05/29/2020 08:34 AM ET) Add Compare Share Today's RangeC$0.03Now: C$0.03▼C$0.0350-Day Range N/A52-Week RangeC$0.03Now: C$0.03▼C$0.64Volume292,285 shsAverage Volume79,508 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartCompetitorsInsider TradesHeadlines Matica Enterprises Inc. focuses on medical marijuana business. It also holds interest in the Grumpy Lizard project in Nevada, the United States; and an option agreement to acquire a 100% interest in the Buckingham North property, a graphite project located east of Ottawa/Gatineau. The company was formerly known as Matica Graphite Inc. and changed its name to Matica Enterprises Inc. in July 2014. Matica Enterprises Inc. is headquartered in Toronto, Canada.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Matica Enterprises. Previous Next 2.7 Community Rank Outperform VotesMatica Enterprises has received 96 “outperform” votes. (Add your “outperform” vote.)Underperform VotesMatica Enterprises has received 85 “underperform” votes. (Add your “underperform” vote.)Community SentimentMatica Enterprises has received 53.04% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Matica Enterprises and other stocks. Vote “Outperform” if you believe MMJ will outperform the S&P 500 over the long term. Vote “Underperform” if you believe MMJ will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldMatica Enterprises does not currently pay a dividend.Dividend GrowthMatica Enterprises does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Matica Enterprises insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.54 out of 5 stars Industry, Sector and Symbol Stock Exchange CNSX Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolCNSX:MMJ Previous Symbol CUSIPN/A CIKN/A Webwww.maticaenterprises.com Phone+1-416-3049935Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable TSXV:MMJ Rates by TradingView Receive MMJ News and Ratings via Email Sign-up to receive the latest news and ratings for MMJ and its competitors with MarketBeat's FREE daily newsletter. Matica Enterprises (CNSX:MMJ) Frequently Asked Questions Has Matica Enterprises been receiving favorable news coverage? News coverage about MMJ stock has trended somewhat positive on Friday, InfoTrie reports. The research firm rates the sentiment of media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Matica Enterprises earned a daily sentiment score of 1.6 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 2.0 out of 10, meaning that recent media coverage is very unlikely to have an impact on the company's share price in the next few days. View the latest news aboutMatica Enterprises. Who are some of Matica Enterprises' key competitors? Some companies that are related to Matica Enterprises include Abattis Bioceuticals (ATTBF), ABcann Global (ABCN), ABZENA/PAR VTG FPD 0.002 (ABZA), Admedus (AHZ), Almirall (LBTSF), Amarantus Bioscience (AMBS), Antibe Therapeutics (VBIZF), Apotheca Biosciences (CBDC), Arno Therapeutics (ARNI), Axim Biotechnologies (AXIM), Baudax Bio (BXRXV), BerGenBio ASA (BRRGF), Biocure Technology (CURE), Canada House Wellness Group (CHV) and Cannabics Pharmaceuticals (CNBX). View all competitors. What other stocks do shareholders of Matica Enterprises own? Based on aggregate information from My MarketBeat watchlists, some companies that other Matica Enterprises investors own include Canopy Rivers (RIV), OrganiGram (OGI), Aurora Cannabis (ACB), Eguana Technologies (EGT), APHRIA INC-TS (APH), Aurora Cannabis (ACB), Cronos Group (MJN), Energous (WATT), Canopy Growth (CGC) and Forum Uranium (FDC). Who are Matica Enterprises' key executives? Matica Enterprises' management team includes the following people: Mr. Boris Ivan Ziger, Chairman & CEOMr. George Andrew Brown, Interim CFO & Director (Age 63)Mr. Donald Shaxon, VP of Corp. Devel. What is Matica Enterprises' stock symbol? Matica Enterprises trades on the CNSX under the ticker symbol "MMJ." What is Matica Enterprises' stock price today? One share of MMJ stock can currently be purchased for approximately C$0.03. What is Matica Enterprises' official website? The official website for Matica Enterprises is www.maticaenterprises.com. How can I contact Matica Enterprises? Matica Enterprises' mailing address is 44 Victoria St Suite 1102, TORONTO, ON M5C 1Y2, Canada. The company can be reached via phone at +1-416-3049935. This page was last updated on 5/29/2020 by MarketBeat.com Staff
